J.L. Sánchez‐Carazo

Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry

P. Dávila‐Seijo, E. Daudén, M.Á. Descalzo et al. · Journal of Investigative Dermatology · 2016 · 125 citations · Full text

Medicine, Dermatology, Pharmacotherapy +9

Survival of classic and biological systemic drugs in psoriasis: results of the <scp>BIOBADADERM</scp> registry and critical analysis

P. Dávila‐Seijo, E. Daudén, G. Carretero et al. · Journal of the European Academy of Dermatology and Venereology · 2016 · 98 citations

Pharmacy, Dermatology, Pharmacotherapy +17

Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5‐year observational study of clinical practice: 2008–2013 results of the Biobadaderm registry

G. Carretero, E. Daudén, Francisco Vanaclocha Sebastián et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 67 citations · Full text

Public Health, Biostatistics, Pharmacotherapy +13

Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national <scp>BIOBADADERM</scp> registry

Carolina Medina, G. Carretero, Carlos Ferrándiz et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 54 citations · Full text

Medicine, Dermatology, Geriatric Medicine +13

Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert Recommendations

J.M. Carrascosa, P. de la Cueva, M. Ara et al. · Actas Dermo-Sifiliográficas · 2016 · 37 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14